Results 121 to 130 of about 422,721 (328)

Deepr: A Convolutional Net for Medical Records

, 2016
Feature engineering remains a major bottleneck when creating predictive systems from electronic medical records. At present, an important missing element is detecting predictive regular clinical motifs from irregular episodic records.
Nguyen, Phuoc, Tran, Truyen, Venkatesh, Svetha, Wickramasinghe, Nilmini   +3 more
core   +1 more source

The Risk of Thromboembolic Complications in Fontan Patients with Atrial Flutter/fibrillation Treated with Electrical Cardioversion [PDF]

, 2016
Atrial flutter or fibrillation (AFF) remains a major chronic complication of the Fontan procedure. This complication further predisposes this patient population to thromboembolic events.
Cordes, Timothy M., Kean, Adam C., Lin, Jiuann-Huey I.   +2 more
core   +1 more source

Leadless Versus Transvenous Dual‐Chamber Pacemakers: Real‐World Evidence From AVEIR DR Coverage With Evidence Development Study

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background AVEIR DR, an industry‐first dual‐chamber leadless pacemaker (LP), provides continuous atrioventricular synchrony through implant‐to‐implant (i2i) communication between atrial and ventricular LP devices. It is important to evaluate the early real‐world comparative safety of AVEIR DR LP.
Monica Lo, Anish K. Amin, Marcin Kowalski, Anne Kroman, Dilip Mathew, Valay Parikh, Stanislav Weiner, Jennifer M. Joseph, Leonard Ganz, Mohammed Mortada, AVEIR DR Study Group/Consortium   +10 more
wiley   +1 more source

Intravenous pacemaker lead implantation for a pediatric patient: A 16-year follow-up study

Journal of Arrhythmia, 2013
Intravenous pacemaker lead implantation for small children is not performed routinely. Here, we report the case of a pediatric patient who underwent endocardial lead implantation and follow-up for 16 years.
Susumu Nakamoto, Kosuke Fujii, Takako Nishino, Takuma Satus, Tatsuya Ogawa, Toshio Kaneda, Toshihiko Saga   +6 more
doaj   +1 more source

Cavotricuspid isthmus angiography predicts atrial flutter ablation efficacy in 281 patients randomized between 8 mm- and externally irrigated-tip catheter [PDF]

, 2006
Antoine Da Costa
openalex   +1 more source

Electrocardiographic Diagnosis of Atrial Tachycardia: Classification, P-Wave Morphology, and Differential Diagnosis with Other Supraventricular Tachycardias [PDF]

, 2014
Atrial tachycardia is defined as a regular atrial activation from atrial areas with centrifugal spread, caused by enhanced automaticity, triggered activity or microreentry.
Buttà, C, Giarrusso, L, PINTO, Antonio, TUTTOLOMONDO, Antonino   +3 more
core   +1 more source

Impact of Pulsed Field Ablation Dosing on Outcome After Pulmonary Vein Isolation Using a Pentaspline Ablation Catheter: A Prospective Comparison of 8 Versus 16 Applications

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background Pulsed field ablation (PFA) is a novel, non‐thermal ablation modality to achieve pulmonary vein isolation (PVI) for the treatment of atrial fibrillation (AF). For the pentaspline catheter, eight applications per pulmonary vein (PV) are considered standard, with four in basket configuration and four in flower configuration.
Katharina Ji‐Mi Yang, Maximilian Spieker, Stephan Angendohr, Carsten auf der Heiden, David Glöckner, Roberto Sansone, Malte Kelm, Alexandru Gabriel Bejinariu, Obaida Rana   +8 more
wiley   +1 more source

Thromboembolic risk in atrial flutter. The FLASIEC (FLutterAtrialeSocietàIaliana diEcografiaCardiovascolare) multicentre study [PDF]

, 2001
Giovanni Corrado
openalex   +1 more source

Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring: A Randomized Clinical Trial.

Circulation, 2019
Background: Advanced generation ablation technologies have been developed to achieve more effective pulmonary vein isolation (PVI) and minimize arrhythmia recurrence following atrial fibrillation (AF) ablation.
J. Andrade, B. Glover, J. Champagne, M. Dubuc, M. Deyell, A. Verma, L. Macle, P. Leong-Sit, P. Novak, Mariano Badra-Verdu, J. Sapp, I. Mangat, C. Khoo, C. Steinberg, M. Bennett, A. Tang, P. Khairy   +16 more
semanticscholar   +1 more source

GLP‐1 Receptor Agonists for the Prevention of New‐Onset Heart Failure: A Systematic Review and Meta‐Analysis of Placebo‐Controlled Randomized Clinical Trials

Obesity Reviews, EarlyView.
ABSTRACT Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RA) improve outcomes in heart failure (HF) with preserved ejection fraction. Whether GLP‐1 RA prevent new‐onset HF in Type 2 diabetes or obesity requires further investigation. Methods We performed an updated meta‐analysis of randomized placebo‐controlled trials (RCT) of treatment ...
João Sérgio Neves, Carolina B. Lobato, Ana Rita Leite, Catarina Vale, Francisco Vasques‐Nóvoa, Francisca Saraiva, Adelino Leite‐Moreira, Jens J. Holst, João Pedro Ferreira   +8 more
wiley   +1 more source